Market map
Pharma & Drug Discovery
The pharma and drug discovery sector is rapidly evolving as advanced computation and artificial intelligence redefine traditional research methodologies, driving significant public market listings and robust private funding rounds for platforms accelerating therapeutic pipeline development.
17 companies, 9 sub-segments, from our own research
The desk's read
AI drug discovery is highly crowded, featuring numerous prominent players like Recursion, Exscientia, and Insilico Medicine that dominate the market space with scaled computational platforms.
Niche sub-segments such as literature search and translational prediction remain sparsely populated, with single representatives like Causaly and VeriSIM Life leading these specialized functional areas.
Capital heavily concentrates in established AI drug discovery and structure-based design giants, with Recursion and Relay Therapeutics commanding the largest funding pools in the ecosystem.
Buyers should watch emerging series-stage innovators in clinical trial design and simulation, as platforms like Unlearn.AI and InSilicoTrials modernize the late-stage drug development pipeline.
AI drug discovery
9
Structure based design
1
Computational chemistry
1
Antibody discovery
1
Clinical trial design
1
Literature search and synthesis
1
Protein therapeutics
1
Translational prediction
1
Clinical trial simulation
1
Our own research, our own segmentation. Browse every Pharma & Drug Discovery company or open the full database.